How was the vaccine candidate approved without efficacy data – i.e. without any data from phase 3 clinical trials? Where are the minutes of the meeting that deliberated on Bharat Biotech’s application and Covaxin’s eventual approval? What does the language the Drug Controller General of India (DCGI) used to approve Covaxin really mean, considering they appear to have been a bit of creative writing? In fact, as the DCGI was approving the vaccine candidates, one more controver